logo
Twitter
Discord
Email
logo
Centene Corporation

Centene Corporation

NYSE•CNC
CEO: Ms. Sarah M. London
Sector: Healthcare
Industry: Medical - Healthcare Plans
Listing Date: 2001-12-13
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children's health insurance program, foster care, medicare-medicaid plans, long-term services and support. This segment also provides healthcare products. The Medicare segment offers special needs and medicare supplement, and prescription drug plans. The Commercial segment provides health insurance marketplace product for individual, small, and large group commercials. It also operates clinical healthcare and pharmacies, as well as offers dental and speech therapy services. In addition, the company engages in the government contracts business under the TRICARE program and other healthcare related government contracts. It provides services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in Saint Louis, Missouri.
Contact Information
Centene Plaza, 7700 Forsyth Boulevard, Saint Louis, MO, 63105, United States
314-725-4477
www.centene.com
Market Cap
$18.34B
P/E (TTM)
-3.5
vs Industry 18.3
Dividend Yield (TTM)
--
52W High
$66.81
52W Low
$25.08
52W Range
29%
6.0
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Strong • 6 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024

Financial Dashboard

Q3 2025 Data

Revenue

$49.69B+0.00%
4-Quarter Trend

EPS

-$13.50+0.00%
4-Quarter Trend

FCF

$0.00+0.00%
4-Quarter Trend

Earnings Highlights

Key Highlights

No Data Available

Risk Factors

No Data Available

Outlook

No Data Available

Peer Comparison

Revenue (TTM)

Centene CorporationCNC
$178.19B
+13.0%
Molina Healthcare, Inc.MOH
$43.41B
+16.1%
Fresenius Medical Care AGFMS
$21.22B
+0.5%

Gross Margin (Latest Quarter)

Incyte CorporationINCY
93.5%
+2.4 pp
Universal Health Services, Inc.UHS
90.2%
+0.2 pp
United Therapeutics CorporationUTHR
89.0%
-0.1 pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
UTHR$20.59B15.718.7%0.0%
WST$20.49B41.917.7%7.7%
WAT$20.44B30.935.0%32.6%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4-Quarter Revenue CAGR
+6.8%
Steady Growth
4-Quarter Net Income CAGR
N/M
Profitability Shift Observed
Cash Flow Stability
50%
Cash Flow Requires Attention

Research & Insights

Reports
All Years
  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Jul 25, 2025|
    Revenue: $48.74B+22.4%
    |
    EPS: $-0.51-123.6%
    Miss
  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: Apr 25, 2025|
    Revenue: $46.62B+15.4%
    |
    EPS: $2.64+21.7%
    Beat
  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 18, 2025|
    Revenue: $163.07B+5.9%
    |
    EPS: $6.33+27.4%
    Beat
  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Oct 25, 2024|
    Revenue: $42.02B+10.5%
    |
    EPS: $1.37+57.5%
    Meet
  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Jul 26, 2024|
    Revenue: $39.84B+5.9%
    |
    EPS: $2.16+11.9%
    Meet
  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: Apr 26, 2024|
    Revenue: $40.41B+3.9%
    |
    EPS: $2.17+5.9%
    Beat
  • Form 10-K - FY 2023

    Period End: Dec 31, 2023|Filed: Feb 20, 2024|
    Revenue: $154.00B+6.5%
    |
    EPS: $4.97+137.8%
    Beat
  • Form 10-Q - Q3 2023

    Period End: Sep 30, 2023|Filed: Oct 24, 2023|
    Revenue: $38.04B+6.1%
    |
    EPS: $0.87-32.6%
    Miss